244 related articles for article (PubMed ID: 32210106)
1. Ellagic Acid Containing Nanostructured Lipid Carriers for Topical Application: A Preliminary Study.
Singh Hallan S; Sguizzato M; Pavoni G; Baldisserotto A; Drechsler M; Mariani P; Esposito E; Cortesi R
Molecules; 2020 Mar; 25(6):. PubMed ID: 32210106
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O
Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933
[TBL] [Abstract][Full Text] [Related]
3. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
Zhang S; Wang J; Pan J
Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid.
Ruktanonchai U; Bejrapha P; Sakulkhu U; Opanasopit P; Bunyapraphatsara N; Junyaprasert V; Puttipipatkhachorn S
AAPS PharmSciTech; 2009; 10(1):227-34. PubMed ID: 19280350
[TBL] [Abstract][Full Text] [Related]
5. Cellular interactions and photoprotective effects of idebenone-loaded nanostructured lipid carriers stabilized using PEG-free surfactant.
Kyadarkunte AY; Patole MS; Pokharkar VB
Int J Pharm; 2015 Feb; 479(1):77-87. PubMed ID: 25545795
[TBL] [Abstract][Full Text] [Related]
6. Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release.
Luan J; Zhang D; Hao L; Li C; Qi L; Guo H; Liu X; Zhang Q
Drug Deliv; 2013 Nov; 20(8):324-30. PubMed ID: 24032657
[TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.
Safwat S; Ishak RAH; Hathout RM; Mortada ND
Drug Dev Ind Pharm; 2017 Jul; 43(7):1112-1125. PubMed ID: 28276784
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles as carriers of cyclodextrin inclusion complexes: A promising approach for cutaneous delivery of a volatile essential oil.
Pires FQ; da Silva JKR; Sa-Barreto LL; Gratieri T; Gelfuso GM; Cunha-Filho M
Colloids Surf B Biointerfaces; 2019 Oct; 182():110382. PubMed ID: 31352250
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization.
Khan S; Shaharyar M; Fazil M; Baboota S; Ali J
Eur J Pharm Biopharm; 2016 Nov; 108():277-288. PubMed ID: 27449630
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
Okonogi S; Riangjanapatee P
Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
[TBL] [Abstract][Full Text] [Related]
13. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
[TBL] [Abstract][Full Text] [Related]
14. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
15. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
Mennini N; Cirri M; Maestrelli F; Mura P
Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
[TBL] [Abstract][Full Text] [Related]
16. Topical phenytoin nanostructured lipid carriers: design and development.
Motawea A; Borg T; Abd El-Gawad AEH
Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451
[TBL] [Abstract][Full Text] [Related]
17. L-dopa co-drugs in nanostructured lipid carriers: A comparative study.
Cortesi R; Esposito E; Drechsler M; Pavoni G; Cacciatore I; Sguizzato M; Di Stefano A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():168-176. PubMed ID: 28024573
[TBL] [Abstract][Full Text] [Related]
18. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation.
Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.
Yuan H; Wang LL; Du YZ; You J; Hu FQ; Zeng S
Colloids Surf B Biointerfaces; 2007 Nov; 60(2):174-9. PubMed ID: 17656075
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles.
Mady FM; Shaker MA
Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
